Transfusion practices in cardiac valve surgery remain variable despite evidence supporting integrated patient blood management strategies. This study evaluated the independent and combined effects of preoperative hemoglobin status and intraoperative blood conservation techniques on transfusion requirements in elective open cardiac valve surgery. We conducted a nationwide retrospective multicenter cohort study using data from the national Maturity Assessment Model for Patient Blood Management registry. Adult patients undergoing elective open cardiac valve surgery between 2016 and 2022 in 23 Spanish hospitals were included. Anemia was defined as preoperative hemoglobin <13 g/dL, irrespective of sex. The primary outcome was red blood cell transfusion during the index hospital admission. A total of 9889 patients were analyzed, with an overall transfusion rate of 53%. Anemic patients (37.3%) had higher transfusion rates than non-anemic patients (70.2% vs. 42.7%). In a separate model restricted to 5763 patients with intraoperative data, combined use of tranexamic acid and intraoperative cell salvage was associated with lower transfusion risk compared with no blood conservation strategy (47.7% vs. 52.3%; adjusted odds ratio 0.83; 95% confidence interval 0.71-0.97), whereas use of either strategy alone showed no meaningful transfusion reduction. When preoperative hemoglobin status and intraoperative strategies were analyzed jointly, the lowest transfusion rate (37.6%) occurred in non-anemic patients receiving both strategies, whereas anemic patients without blood conservation had the highest rate (74.9%; adjusted odds ratio 4.95; 95% confidence interval 4.10-5.97). Combined implementation of adequate preoperative hemoglobin levels and intraoperative blood conservation strategies was associated with lower transfusion rates in elective cardiac valve surgery, supporting the value of integrated perioperative patient blood management pathways in real-world practice.
1 January 2010 in Revista Española de Anestesiología y Reanimación
Background/Objectives: Sex-specific anemia criteria classify women with hemoglobin (Hb) 12.0–12.9 g/dL as non-anemic. We assessed whether World Health Organization (WHO) criteria underrecognize red blood cell (RBC) transfusion risk compared with a uniform patient blood management (PBM) threshold of Hb <13.0 g/dL in elective open cardiac valve surgery (CVS). Methods: This nationwide retrospective cohort included adults undergoing elective open CVS in 40 Spanish centers (2016–2024), 32 of which reported preoperative Hb. Hb was modeled continuously and in three strata (<12.0, 12.0–12.9, ≥13.0 g/dL). The primary outcome was RBC transfusion; secondary outcomes were postoperative complications, length of stay, and in-hospital mortality within 30 days. Mixed-effects models adjusted for age, comorbidity burden, surgical complexity, valve position, year of surgery, and center. Results: Among 29,757 eligible patients, 20,017 had available Hb measurements; 9247 (46.2%) were women, including 2333 (25.2%) with Hb 12.0–12.9 g/dL. In this stratum, 68.0% of women and 52.7% of men received RBC transfusions. The adjusted between-sex probability difference was 15.1 percentage points (95% CI, 11.4–18.9; adjusted odds ratio, 1.85; 95% CI, 1.59–2.16). The categorical sex × Hb interaction was significant (p < 0.001), whereas the continuous interaction was not (p = 0.486). Sex did not significantly modify the Hb associations with complications or in-hospital mortality within 30 days. Conclusions: Women with Hb 12.0–12.9 g/dL had substantial transfusion risk despite being classified as non-anemic by the WHO criteria. Hb <13.0 g/dL may be a pragmatic sex-inclusive trigger for perioperative risk recognition and etiologic evaluation, not a proven therapeutic target.
1 January 2022 in Revista Española de Anestesiología y Reanimación